Abiopharma

Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

RedHill Biopharma - RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights

IM Cannabis Regains Compliance with Nasdaq Stockholders Equity Listing Requirement

RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights

OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.

Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program

RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights

New Form 6-K - Haleon plc Filed: 2025-09-05 AccNo: 0001654954-25-010427 Size: 39 KB

Akari Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

New Form 6-K - BioNTech SE Filed: 2025-09-05 AccNo: 0001776985-25-000055 Size: 110 KB

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 6-K - HUTCHMED Filed: 2025-09-05 AccNo: 0001648257-25-000059 Size: 80 KB

Response to SGX Queries:

Director M33 Growth I L.P. 🔴 sold 6.7M shares of Oncology Institute, Inc. (TOI) at $3.09 ($20.7M) Transaction Date: Sep 04, 2025 | Filing ID: 084700

New Form 6-K - Apollomics Inc. Filed: 2025-09-05 AccNo: 0001193125-25-196482 Size: 32 KB